POSTER SESSION V
Wednesday, March 11, 2009   —  9:30 AM - 12:00 Noon
Convention Center Exhibit Hall


Click on the blue numbers in parentheses to display abstracts.
Click the button next to any title to add to Itinerary Planner...


DERMATOPATHOLOGY



Poster#Title and AuthorsItinerary
Planner
39 Defining Histopathologic Criteria of Cutaneous Metastatic Melanomas: A Clinicopathologic Study of 160 Cases with Emphasis on the Morphologic Spectrum (480)
JA Plaza, C Torres-Cabala, H Evans, H Diwan, VG Prieto - Medical College of Wisconsin, Milwaukee, WI; MD Anderson Cancer Center, Houston, TX 		Add
40 Prognostic Significance of CCR10 and CCL27 Expression in Primary and Metastatic Cutaneous Malignant Melanoma (475)
C Monteagudo, D Ramos, A Pellin-Carcelen, JA Lopez-Guerrero, V Alonso, E Jorda, A Pellin - University of Valencia, Valencia, Spain; Fundacion Instituto Valenciano de Oncologia, Valencia, Spain; Hospital Clinico Universitario, Valencia, Spain 		Add
41 Neuropilin-2 Expression in Normal Tissues, Various Tumors, and Primary and Metastatic Melanomas (484)
EC Rushing, MJ Keefe, S Khanna, AA Jungbluth, KJ Busam, RM Alani - The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD; Cleveland Clinic, Cleveland, OH; Johns Hopkins University School of Medicine, Baltimore, MD; Ludwig Institute for Cancer Research, New York, NY; Memorial Sloan-Kettering Cancer Center, New York, NY 		Add
42 MicroRNA Expression Profiles Differentiate Spitz Nevus from Primary Malignant Melanoma (454)
CI Garady, J Chen, N Zhang, H Feilotter, V Tron - Queen's University, KIngston, ON, Canada 		Add
43 Differentiating Melanoma In Situ from Severely Dysplastic Nevus with Anti-MART-1 Versus Anti-MiTF Immunohistochemistry: The Arkansas Experience (453)
AJ Finn, BR Smoller, KM Hiatt - University of North Carolina Hospitals, Chapel Hill, NC; University of Arkansas for Medical Sciences, Little Rock, AR 		Add
44 Comparative Expression of CXCR3 Chemokine Receptor and Their Ligands (CXCL9, CXCL10 and CXCL11) in Cutaneous Melanoma Progression (479)
A Pellin-Carcelen, D Ramos, J Martin, E Jorda, A Pellin, C Monteagudo - University of Valencia, Valencia, Spain; Hospital Clinico Universitario, Valencia, Spain 		Add
45 A Novel Candidate Gene for Promotion of Melanoma Progression (458)
B Horst, K Chernoff, L Bordone, G Brunner, J Celebi - UCLA, LA, CA; Columbia University, NY, NY; Fachklinik Hornheide, Muenster, Germany 		Add
46 BD ProEx™ C Immunostaining in Cutaneous Melanocytic Lesions (465)
M Li, D Frishberg, AE Walts, S Bose - Cedars-Sinai Medical Center, Los Angeles, CA 		Add
47 Melanocytic Tumors Express Connexin 43 but Not 26, a Immunohistochemical Analysis in Histologic Materials and Potential Significance of the Findings in Melanocytic Oncogenesis (456)
RH Gormley, T Pasha, H Niu, G Acs, X Xu, PJ Zhang - University of Pennsylvania, Philadelphia, PA; H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL 		Add
48 C-Kit Expression in Cutaneous Melanoma. In Vitro Effects of Drugs Targeting C-Kit (492)
A Sorolla, M Mayorga, A Yeramian, AM Perez de Santos, A Velasco, R Egido, L Abal, X Matias-Guiu, RM Marti - Hospital Universitari Arnau de Vilanova, Lleida, Spain 		Add
49 Microscopic Imaging of Lymphangiogenesis in Cutaneous Malignant Melanoma: Still a Questionable Predictor of Sentinel Lymph Node Metastasis (451)
G Falconieri, G DeMaglio, D Camilot, S Pizzolitto - General Hospital, Udine, Italy 		Add
50 Superficial Micronodules of Pregnancy and MIB-1 (Ki-67) Proliferation Index in Benign Nevi Excised during Pregnancy (445)
MP Chan, MM Chan, SR Tahan - Beth Israel Deaconess Medical Center, Boston, MA 		Add
51 Long Term Follow-Up in Patients with Pigmented Epithelioid Melanocytoma (470)
RV Mandal, R Murali, KF Lundquist, BD Ragsdale, PJ Heenan, SW McCarthy, MJ Mihm, RA Scolyer, A Zembowicz - Massachusetts General Hospital, Boston, MA; Royal Prince Alfred Hospital, Camperdown, NSW, Australia; Central Coast Pathology, San Luis Obispo, CA; Cutaneous Pathology, Nedlands, Western Australia, Australia; Lahey Clinic, Burlington, MA; DermatopathologyConsultations.com, Belmont, MA 		Add
52 Quantitative Evaluation of Activated Cytotoxic Lymphocytes in Melanocytic Lesions Using Laser Confocal Microscopy (474)
EC Miller, L Ang, M Dahiya, SR Tahan - Beth Israel Deaconess Medical Center, Boston, MA; Loyola University Medical Center, Chicago, IL; Harvard Medical School, Boston, MA 		Add
53 Dermal Analysis of CDKN1B (P27) Is the Most Useful Cell Cycle Regulator for Grading of Atypical Melanocytic Nevi (459)
EA Husain, C Main, L Pozo, A Blanes, SJ Diaz-Cano - Barts and The London Hospital, London, United Kingdom; Homerton University Hospital, London, United Kingdom; University of Malaga School of Medicine, Malaga, Spain; King's College Hospital, London, United Kingdom 		Add
54 Matrix Metalloproteinase-9 and Vascular Endothelial Growth Factor Are Regulated by Histone Lysine Specific Demethylase 2 in Cultured Human Melanoma Cells (466)
C Lian, B Lian, M Hsu, Y Shi, B Woda, A Deng, R Han - University of Massachusetts, Worcester, MA; Brigham & Women's Hospital, Harvard Medical School, Boston; Brigham & Women's Hospital, Harvard Medical School, Boston, MA 		Add
55 Detection of `Merkel Cell Polyoma Virus' in Cases of Paraffin-Embedded Merkel Cell Carcinoma (449)
J Duncavage, JD Pfeifer - Washington University, Saint Louis, MO 		Add
56 Merkel Cell Carcinoma of the Skin: A New Type of Virus-Associated Human Tumour (488)
X Sastre-Garau, M Peter, MF Avril, H Laude, J Couturier, F Rozenberg, A Almeida, F Boitier, A Carlotti, B Couturaud, N Dupin - Institut Curie, Paris, France; Groupe Hospitalier Cochin-St Vincent de Paul, Paris, France 		Add
57 E-Cadherin and b -Catenin Are Dysregulated in Merkel Cell Carcinomas (489)
S Serra, D Ghazarian, R Chetty - UHN, University of Toronto, Toronto, Canada 		Add
58 Clinicopathological & Immunohistochemical Features of Cutaneous Squamous Cell Carcinomas of the Lip (478)
JZ Pat, RS Krause, M Raju, WH Leyva, AR Prasad - University of Arizona, Tucson, AZ; Southern Arizona VA Health Care System, Tucson, AZ; University of Washington, Seatle, WA 		Add
59 Immunopathological Features of Cutaneous Squamous Cell Carcinomas in Immunocompromised Patients (495)
CM Valentino, R Krouse, D Bradely-Dunlop, R Nagle, E Akporiaye, A Prasad - University of Arizona, Tucson, AZ; United States Department of Veteran Affairs, Tucson, AZ 		Add
60 Cutaneous Squamous Cell Carcinoma - One Year Experience of a Single Dermatopathology Service at a University Based Academic Medical Center (497)
RK Virk, R Han, A Deng - UMass Memorial Hospital, Worcester, MA 		Add